Emcure plea to direct NPPA to review HIV drugs price junked by DoP Farhat Nasim3 Feb 2020 8:11 AM GMTNew Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to dir...
